Pharmacists completing the Pediatric Pharmacy Residency Program will be able to provide proficient, confident, and compassionate direct patient care in multiple pediatric patient environments.

 

Group picture of pediatric pharmacy residents.

Practitioners will be accountable for promoting safe and effective drug usage and achieving optimal drug therapy outcomes as vital members of the health care team. Also, because the University of Maryland School of Pharmacy jointly manages this program with the University of Maryland Children's Hospital (UMCH), the pharmacist will be able to exercise skill in educating other health care professionals, patients, and the community on drug therapy-related topics, and will possess skill in conducting pharmacy practice-related research.

As part of its accreditation by the American Society of Health-System Pharmacists (ASHP), this program is committed to the following general purpose:

Postgraduate Year 2 (PGY2) pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and Postgraduate Year 1 (PGY1) pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Additionally, our program adheres to the Goals and Objectives for a Post-Graduate Year Two Program in Pediatric Pharmacy set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.

Required Learning Experiences:

  • Orientation (1 month)
  • General Pediatrics (1 month)
  • Pediatric Subspecialties—Hematology/Oncology, GI, and Cardiology (1 month)
  • Neonatal Intensive Care Unit (NICU) (1 month)
  • Pediatric Intensive Care Unit (PICU) (1 month)
  • Pediatric Emergency Department (1 month)
  • Pediatric Toxicology (Maryland Poison Center) (1 month)
  • Pediatric Ambulatory Care (Pediatric GI Clinic) (longitudinal)
  • Pediatric Clinical and Operations Weekend support (longitudinal)

Elective Rotation Opportunities:

Each resident will have the opportunity to customize his or her residency experience with the program director.

Other Learning Experiences:

In addition to the pharmacy practice experiences outlined above, the resident will also have the opportunity to participate in the following longitudinal learning experiences:

Teaching/Academia:

  • The resident is required to complete approximately 40 hours of teaching each semester.
  • Residents are appointed as clinical instructors at the University of Maryland School of Pharmacy.
  • One hour of teaching in the Pediatric Elective is required.
  • Other teaching activities may include didactic lectures, small group discussions, and skills laboratories.
  • A teaching certificate program is available for interested residents.

Scholarship Experiences:

The resident is required to complete the following scholarship activities:

  • Conduct one longitudinal research project
  • A final manuscript of the research project must be prepared in a publishable format
  • Presentation of interim or final results of research project at the Pediatric Pharmacy Association Annual meeting
  • Complete one medication utilization evaluation (MUE) or management project
  • Newsletter article or other scholarly activity

Professional Development Experiences
The resident will also participate in the following professional development activities:

  • Pharmacotherapy Rounds
  • UMMC Pediatric P&T Committee participation 
  • UMMC Pediatric Medication Safety Workgroup participation
  • Professional Development Series
  • Community Service Activity
  • Case Conference presentation
  • Journal Club/Literature Update presentation
  • Pediatric journal club presentation

Participation in Pharmacotherapy Rounds, Professional Development lecture series, and staffing responsibilities is a requirement of all University of Maryland residents. For more information about these specific activities, please visit the Residency & Fellowship Requirements webpage.

About the University of Maryland Childrens Hospital (UMCH):

In providing the best possible care for children of all ages, the University of Maryland Children's Hospital takes the slogan "Children Are Our Future" very seriously. Recognized statewide and regionally as a center of excellence for children with critical illnesses and complex, chronic conditions, UMCH combines state-of-the-art medicine with family-centered care.

There are 145 licensed beds caring for over 20 specialties, with a level IV NICU with 52 beds and a 19-bed PICU/PCICU. There are approximately 4,500 admissions annually, including 1,000 admissions to the PICU/IMC. Our services range from primary care to highly specialized treatment programs that attract patients from the entire mid-Atlantic region.

Core Preceptors:

  • Jessica Biggs, PharmD, BCPPS (NICU)
  • Shawnée Daniel-McCalla, PharmD, BCPPS (NICU)
  • Thomas Laudone, PharmD, BCPPS (Pediatric ED)
  • Cassidy (Casey) Luke, PharmD (Pediatric ED, PICU)
  • Christina Megiel, PharmD, BCPPS (Pediatric Subspecialties and Pediatric ID)
  • Shelby Warring, PharmD, BCPPS (General Pediatrics)
  • Kristine Parbuoni, PharmD, BCPPS (PICU and Academia)
  • Christian Carr Nicolosi, PharmD, BCPPS (PICU CS)
  • Josh King, Md., FACMT (Toxicology/Poison Center)
  • Jill Morgan, PharmD, BCPS, BCPPS (Pediatric Ambulatory Care and Academia)
  • Joetta Wade, PharmD (Pediatric Operations)

Number of Available Positions: 1

Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and Maryland Pharmacy licensure are required. Residents must complete an ASHP-accredited PGY1 residency prior to starting.

Application Process:

The application deadline is January 2.

Applications for this program will only be accepted through PhORCAS. Reference writers should use the standard reference template in PhORCAS.

Application requirements:

  • Letter of intent
  • Curriculum vitae
  • Letters of recommendation (3)
  • Official transcripts

International students and permanent residents should contact P-SHORResidencyandAdministrativeSupport@rx.umaryland.edu before applying.

Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.

Program Director:

Kristine A. Parbuoni, PharmD, BCPPS
Associate Professor and Director of OSCE Programs
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
20 N. Pine Street
Baltimore, MD 21201
Phone: (410) 706-3629
Email: kparbuoni@rx.umaryland.edu

Program Coordinator:

Shawnée Daniel-McCalla, PharmD, BCPPS
Pediatric Clinical Pharmacy Specialist (NICU)
Department of Pharmacy
University of Maryland Medical Center
22 S. Greene Street
Baltimore, MD 21201
Phone: (410) 328-7281
Email: Shawnee.Daniel-McCalla@umm.edu